NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the NIH Director’s Transformative Research Awards, a federal grant aimed at supporting innovative and unconventional research in the biomedical sciences. This opportunity encourages individual scientists or collaborative groups to propose groundbreaking projects that have the potential to significantly impact scientific paradigms or clinical approaches, with no preliminary data required for application. The total estimated funding for this program is $8 million, with approximately seven awards expected to be granted, and interested applicants can reach out to the NIH Director's Transformative Research Award Program via email at Transformative_Awards@mail.nih.gov. Key deadlines include the synopsis close date on September 3, 2026, and the estimated award date on August 30, 2027.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government, excluding the NIH Intramural Research Program (NIH IRP);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).